WEST PHARMACEUTICAL SERVICES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $103.50 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-02-17
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $103.50M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $178.70M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $276.90M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $225.60M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2025-12-31 | $103.50M 10-K · filed 2026-02-17 |
| 2024-12-31 | $178.70M 10-K · filed 2025-02-18 |
| 2023-12-31 | $276.90M 10-K · filed 2024-02-20 |
| 2022-12-31 | $225.60M 10-K · filed 2023-02-21 |
| 2021-12-31 | $573.70M 10-K · filed 2022-02-22 |
| 2020-12-31 | $351.70M 10-K · filed 2021-02-23 |
| 2019-12-31 | $158.60M 10-K · filed 2020-02-24 |
| 2018-12-31 | $89.30M 10-K · filed 2019-02-28 |
| 2017-12-31 | $120.90M 10-K · filed 2018-02-26 |
| 2016-12-31 | $153.50M 10-K · filed 2017-02-28 |
| 2015-12-31 | $110.30M 10-K · filed 2016-02-26 |
| 2014-12-31 | $85.60M 10-K · filed 2015-02-25 |
| 2013-12-31 | $67.60M 10-K · filed 2014-02-27 |
| 2012-12-31 | $24.80M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |